The Experiences of Drug List Formulation Procedure Based on Pharmaeconomics and the Enlightenment to China / 中国卫生经济
Chinese Health Economics
;
(12): 94-96, 2018.
Artigo
em Chinês
| WPRIM
| ID: wpr-703518
ABSTRACT
Objectives:
To analyze the role of pharmaeconomics during drug list formulation procedure and the enlightenment to China.Methods:
Using literature review and comparative analysis method, it compared the drug list formulation procedure of WHO, Australia, UK, Tailand and the role of pharmaeconomics.Results:
Using pharmaeconomics method was common in international experience. The methodology of pharmaeconomics was also well developed.Conclusions:
To improve China drug selection procedure, China should enhance government policy invest in pharmaeconomics usage and support the research, break down the grey benefit relation between medicine and medical.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Health Economics
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS